Last update 21 Nov 2024
Yinfenidone Hydrochloride
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms Yifenidone + [3] |
Target |
Mechanism TGF-α inhibitors(Transforming growth factor alpha inhibitors), TGF-β inhibitors(Transforming growth factor beta inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
RegulationOrphan Drug (US) |
Login to view timeline
Related
12
Clinical Trials associated with Yinfenidone HydrochlorideA Phase IIb, Multi-center, Randomized, Double Blinded, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of HEC585 Tablets in Patients With Progressive Fibrosing Interstitial Lung Disease
一项为期24周的随机、双盲、安慰剂平行对照IIb期临床研究，旨在评价盐酸伊非尼酮片在进行性纤维化性间质性肺疾病（PF-ILD）患者中的有效性和安全性
[Translation] A 24-week randomized, double-blind, placebo-controlled, parallel-group Phase IIb clinical study to evaluate the efficacy and safety of ifenidone hydrochloride tablets in patients with progressive fibrosing interstitial lung disease (PF-ILD)
Clinical Trial of Absorption, Metabolism and Excretion of [14C]-HEC585 in Chinese Adult Male Healthy Subjects
100 Clinical Results associated with Yinfenidone Hydrochloride
Login to view more data
100 Translational Medicine associated with Yinfenidone Hydrochloride
Login to view more data
100 Patents (Medical) associated with Yinfenidone Hydrochloride
Login to view more data
100 Deals associated with Yinfenidone Hydrochloride
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Progressive pulmonary fibrosis | Phase 2 | CN | 06 Feb 2023 | |
| Idiopathic Pulmonary Fibrosis | Phase 2 | CN | 22 Jun 2021 | |
| Liver Cirrhosis | IND Application | CN | 20 Jul 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free